Eltropag 50mg Tablet

About

Eltropag 50mg Tablet contains eltrombopag, a thrombopoietin receptor agonist specifically designed to increase platelet production. It works by stimulating the thrombopoietin receptor on megakaryocytes, the precursor cells to platelets, in the bone marrow. This stimulation leads to increased proliferation and differentiation of megakaryocytes, ultimately resulting in a higher number of circulating platelets. This mechanism is crucial for patients suffering from conditions characterized by low platelet counts (thrombocytopenia), where the body's natural ability to produce platelets is impaired or where platelets are excessively destroyed.

This medication is a vital treatment option for chronic immune thrombocytopenia (ITP), severe aplastic anemia (SAA), and thrombocytopenia associated with chronic hepatitis C, particularly when other conventional treatments have been ineffective or are contraindicated. By elevating platelet counts, Eltropag significantly reduces the risk of bleeding events, which can be life-threatening in severe thrombocytopenia. Its oral administration offers convenience, but strict adherence to dosing instructions, especially regarding food and calcium intake, is essential for optimal absorption and efficacy.

Uses

• Treatment of chronic immune thrombocytopenia (ITP)
• Management of severe aplastic anemia (SAA)
• Treatment of chronic hepatitis C-associated thrombocytopenia
• When other treatments for thrombocytopenia are insufficient

Directions For Use

Take orally once daily on an empty stomach, at least 2 hours before or 4 hours after calcium-containing products.

Benefits

• Effectively increases platelet count
• Significantly reduces the risk of bleeding events
• Allows for dose reduction or discontinuation of other ITP treatments
• Improves quality of life for patients with thrombocytopenia
• Effective in refractory cases of ITP and SAA
• Convenient oral administration

Side Effects

• Nausea
• Diarrhea
• Abdominal pain
• Fatigue
• Headache
• Muscle pain (myalgia)
• Abnormal liver function tests
• Cataracts
• Skin rash
• Cough
• Fever
• Increased risk of thrombosis (blood clots)

Safety Measures

• Alcohol - Avoid excessive alcohol consumption as it can exacerbate liver strain and potentially interfere with liver function, which is closely monitored during treatment.
• Pregnancy - Eltropag is contraindicated during pregnancy due to potential for fetal harm. Effective contraception is essential for women of childbearing potential.
• Breastfeeding - Eltropag is contraindicated during breastfeeding. It is unknown if it is excreted in breast milk, but potential for serious adverse effects in the infant exists.
• Liver - Use with extreme caution in patients with liver impairment. Liver function tests must be monitored closely, and dose adjustment is often required.
• Kidney - Use with caution in patients with kidney impairment. No specific dose adjustment is usually required, but monitor renal function regularly.
• Lung - Generally safe for use in patients with lung conditions. No specific lung concerns or adverse effects are typically associated with this medication.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.